IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc., (Nasdaq: SPPI) today announced that Rajesh C. Shrotriya, M.D., Chairman, President and Chief Executive Officer, and other members of senior management, will host a conference call and webcast to provide an update on Ozarelix.
